Holding(s) in Company

RNS Number:7377J
Eidos PLC
14 March 2005

                                  SCHEDULE 10

                   NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Name of company

Eidos plc


2. Name of shareholder having a major interest

The Goldman Sachs Group, Inc.


3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18

Mixture of beneficial and non-beneficial interests


4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them

Holder                                             Status

Goldman Sachs Securities (Nominees), Limited       Custodian                  8,795,317
Goldman, Sachs & Co. (held as ADRs)                Custodian                     45,838
Goldman Sachs International                        Beneficial Interest        2,330,520

Total holding                                                                11,171,675


5. Number of shares / amount of stock acquired since last notification

N/a


6. Percentage of issued class acquired

N/a


7. Number of shares / amount of stock disposed since last notification

2,824,488


8. Percentage of issued class disposed

1.99%


9. Class of security

Ordinary shares of 2 pence each


10. Date of transaction

Not known


11. Date company informed

11 March 2005


12. Total holding following this notification

11,171,675


13. Total percentage holding of issued class following this notification

7.87%


14. Any additional information

Notification received pursuant to S.198 and S.199 (2)(b) - CA '85


15. Name of contact and telephone number for queries

Michael Arnaouti                              020 8636 3000


16. Name and signature of authorised company official responsible for making
this notification

Jonathan Ball


Date of notification

14 March 2005


The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLJIMRTMMTBBBA